Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Acq. announced
|
|
NRX Pharmaceuticals, Inc. (NRXP)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/24/2023 |
4
| Javitt Jonathan C (Chief Scientist) has filed a Form 4 on NRX Pharmaceuticals, Inc.|
Txns:
| Bought 100,000 shares
@ $0.33, valued at
$33k
|
|
| 08/23/2023 |
4
| Javitt Jonathan C (Chief Scientist) has filed a Form 4 on NRX Pharmaceuticals, Inc.|
Txns:
| Bought 200,000 shares
@ $0.322, valued at
$64.4k
|
|
| 12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/18/2022 |
4
| Javitt Daniel C. (10% Owner) has filed a Form 4 on NRX Pharmaceuticals, Inc.|
Txns:
| Sold 133,719 shares
@ $1.02, valued at
$136.4k
Sold 33,018 shares
@ $1.0523, valued at
$34.7k
|
|
| 11/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/02/2022 |
4
| Javitt Daniel C. (10% Owner) has filed a Form 4 on NRX Pharmaceuticals, Inc.|
Txns:
| Sold 784,063 shares
@ $1.0094, valued at
$791.4k
|
|
| 07/05/2022 |
4
| Javitt Daniel C. (10% Owner) has filed a Form 4 on NRX Pharmaceuticals, Inc.|
Txns:
| Gifted 2,000,000 shares
@ $0 |
|
| 06/07/2022 |
4
| Javitt Daniel C. (10% Owner) has filed a Form 4 on NRX Pharmaceuticals, Inc.|
Txns:
| Sold 243,596 shares
@ $0.7024, valued at
$171.1k
Sold 115,657 shares
@ $0.6653, valued at
$76.9k
Sold 86,459 shares
@ $0.6461, valued at
$55.9k
|
|
| 06/02/2022 |
4
| Javitt Jonathan C (Chief Scientist) has filed a Form 4 on NRX Pharmaceuticals, Inc.|
Txns:
| Bought 100,000 shares
@ $58, valued at
$5.8M
|
|
| 03/10/2022 |
4
| Besthof Robert (Interim CEO) has filed a Form 4 on NRX Pharmaceuticals, Inc.|
Txns:
| Granted 100,000 options to buy
@ $2.61, valued at
$261k
|
|
| 11/02/2021 |
4
| McMaster Herbert Raymond (Director) has filed a Form 4 on NRX Pharmaceuticals, Inc.|
Txns:
| Exercised 18,300 shares
@ $2.22, valued at
$40.6k
Converted 28,724 options to buy
@ $2.22, valued at
$63.8k
Granted 10,424 restricted stock units
@ $0 |
|
| 11/02/2021 |
4
| Javitt Daniel C. (10% Owner) has filed a Form 4 on NRX Pharmaceuticals, Inc.|
Txns:
| Gifted 434,594 shares
@ $0 |
|
| 11/02/2021 |
4
| Daigneault Alessandra (General Counsel & Secretary) has filed a Form 4 on NRX Pharmaceuticals, Inc.|
Txns:
| Exercised 27,395 shares
@ $3.07, valued at
$84.1k
Sold 33,715 shares
@ $13.11, valued at
$442k
Exercised 18,420 shares
@ $3.07, valued at
$56.5k
Exercised 13,164 shares
@ $3.07, valued at
$40.4k
Converted 43,000 options to buy
@ $3.07, valued at
$132k
Granted 15,605 restricted stock units
@ $0
Converted 28,916 options to buy
@ $3.07, valued at
$88.8k
Converted 20,666 options to buy
@ $3.07, valued at
$63.4k
Granted 10,496 restricted stock units
@ $0
Granted 7,502 restricted stock units
@ $0 |
|
| 11/02/2021 |
4
| Besthof Robert (Chief Comm. & Patient Officer) has filed a Form 4 on NRX Pharmaceuticals, Inc.|
Txns:
| Exercised 63,710 shares
@ $0.2, valued at
$12.7k
Sold 40,000 shares
@ $11.76, valued at
$470.4k
Converted 100,000 options to buy
@ $0.2, valued at
$20k
Granted 36,290 restricted stock units
@ $0 |
|
| 06/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2021 |
4
| Javitt Daniel C. (10% Owner) has filed a Form 4 on NRX Pharmaceuticals, Inc.|
Txns:
| Granted 13,971,864 shares
@ $0 |
|
| 06/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2021 |
4
| Gorovitz Aaron (Director) has filed a Form 4 on NRX Pharmaceuticals, Inc.|
Txns:
| Granted 8,336 shares
@ $0
Granted 8,336 shares
@ $0
Granted 8,336 shares
@ $0
Granted 16,678 shares
@ $0 |
|
| 06/10/2021 |
4
| Glied Sharon (Director) has filed a Form 4 on NRX Pharmaceuticals, Inc.|
Txns:
| Granted 13,168 shares
@ $0
Granted 65,437 options to buy
@ $0.21, valued at
$13.7k
|
|
| 06/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2021 |
4
| Flynn Patrick John (Director) has filed a Form 4 on NRX Pharmaceuticals, Inc.|
Txns:
| Granted 362,332 shares
@ $0
Granted 35,209 shares
@ $0
Granted 35,209 shares
@ $0
Granted 692,639 warrants
@ $3.08, valued at
$2.1M
Granted 692,639 warrants
@ $3.08, valued at
$2.1M
|
|
| 06/10/2021 |
4
| Daigneault Alessandra (General Counsel & Secretary) has filed a Form 4 on NRX Pharmaceuticals, Inc.|
Txns:
| Granted 6,320 shares
@ $0
Granted 143,840 options to buy
@ $3.08, valued at
$443k
Granted 49,600 options to buy
@ $3.08, valued at
$152.8k
Granted 148,800 options to buy
@ $72.3, valued at
$10.8M
|
|
| 06/10/2021 |
4
| Besthof Robert (Chief Comm. & Patient Officer) has filed a Form 4 on NRX Pharmaceuticals, Inc.|
Txns:
| Granted 347,200 options to buy
@ $0.21, valued at
$72.9k
Granted 347,200 options to buy
@ $3.08, valued at
$1.1M
|
|
| 05/25/2021 |
4
| Big Rock Partners Sponsor, LLC (10% Owner) has filed a Form 4 on NRX Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 5,435 shares
@ $0
Converted 27,250 shares
@ $0
Converted 272,500 options to buy
@ $0
Bought 100,000 options to buy
@ $10, valued at
$1M
|
|
|
|
|